Top rated lung cancer clinical trials in High Point, North Carolina
Here are the top 10 medical studies for lung cancer in High Point, North Carolina
Popular filter options for lung-cancer high-point trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Procedure
Surgery or High-Dose Radiation for Metastatic Breast Cancer
Recruiting1 awardPhase 2 & 3
Chapel Hill, North Carolina
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Anti-metabolites
Pembrolizumab + Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Jonesboro, Arkansas
This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.
Tyrosine Kinase Inhibitor
Cabozantinib for Pancreatic Neuroendocrine Tumors
Recruiting1 awardPhase 3
Washington, District of Columbia
This trial compares cabozantinib to placebo in treating neuroendocrine or carcinoid tumors. Cabozantinib is a chemotherapy drug that targets specific tyrosine kinase receptors, which when blocked, may slow tumor growth.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Anti-metabolites
Docetaxel +3 More for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Augusta, Georgia
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
PARP Inhibitor
M6620 + Irinotecan for Cancer
Recruiting1 awardPhase 1
Chapel Hill, North Carolina
This trial is studying the side effects and best dose of M6620 and irinotecan hydrochloride in treating patients with metastatic solid tumors. M6620 and irinotecan hydrochloride may stop the growth of tumor cells.
View More Lung-cancer High-point Trials
See another 83 medical studies focused on lung-cancer high-point.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.